Common Contracts

Certain identified information has been excluded from this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K because such information both (i) is not material and (ii) would likely cause competitive harm if publicly disclosed. Excluded...

Settlement Agreement • March 31st, 2022 • Abeona Therapeutics Inc. • Pharmaceutical preparations • New York

• Contract Type
  Settlement Agreement
• Filed
  March 31st, 2022
• Company
  Abeona Therapeutics Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Settlement Agreement and Mutual Release (“Settlement Agreement”) is entered into by and between REGENXBIO Inc. (“REGENXBIO”) and Abeona Therapeutics Inc. (“Abeona”) and is effective as of the date of the last signature hereto (the “Effective Date”). REGENXBIO and Abeona are collectively referred to as the “Parties” in this Settlement Agreement, and each a “Party”.

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

Settlement Agreement • March 1st, 2022 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Settlement Agreement
• Filed
  March 1st, 2022
• Company
  REGENXBIO Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Settlement Agreement and Mutual Release (“Settlement Agreement”) is entered into by and between REGENXBIO Inc. (“REGENXBIO”) and Abeona Therapeutics Inc. (“Abeona”) and is effective as of the date of the last signature hereto (the “Effective Date”). REGENXBIO and Abeona are collectively referred to as the “Parties” in this Settlement Agreement, and each a “Party”.